Reuters logo
BRIEF-Imprimis Pharmaceuticals announces $16 mln debt facility with SWK Holdings
July 20, 2017 / 12:38 PM / 5 months ago

BRIEF-Imprimis Pharmaceuticals announces $16 mln debt facility with SWK Holdings

July 20 (Reuters) - Imprimis Pharmaceuticals Inc:

* Imprimis Pharmaceuticals announces $16 million debt facility with SWK Holdings

* Imprimis Pharmaceuticals - plans to use proceeds to retire its existing $13 million term loan with an affiliate of life sciences alternative funding

* Imprimis Pharmaceuticals Inc - loan was fully funded at closing with a five-year term bearing interest, initially, at 12 percent per annum

* Imprimis Pharmaceuticals - also plans to use proceeds to provide additional working capital for its growing ophthalmic formulation pipeline Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below